Regulatory roundup

More healthcare-related regulatory news for plan sponsors, including links to detailed information.

CBO releases analysis on specialty drugs in Medicare Part D and Medicaid
The Congressional Budget Office (CBO) published “Prices for and Spending on Specialty Drugs in Medicare Part D and Medicaid: An In-Depth Analysis.” The report examines the net prices paid for specialty drugs and spending on those drugs in Medicare Part D and Medicaid over the 2010–2015 period. In each program, the net price for many drugs is lower than the amount paid to pharmacies, also referred to as the retail price, because of manufacturers’ rebates and other discounts.

For more information, click here.

Private health insurance enrollment report published
The Government Accountability Office (GAO) released “Private Health Insurance: Enrollment Remains Concentrated Among Few Issuers, Including Exchanges.” The report found that enrollment in private health insurance plans continued to be concentrated among a small number of issuers in 2015 and 2016.

In the overall large group market (coverage offered by large employers), small group market (coverage offered by small employers), and individual market (coverage sold directly to individuals), the three largest issuers held 80% of the market or more in at least 37 of 51 states. This is similar to what GAO previously reported for 2011 through 2014.

For more information, click here.